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Abstract 
Scientific research brings resolutions to several 
problems in society, supporting clinical performance in 
health. Work with cancer patients needs to be even 
more careful. During the COVID-19 pandemic, cancer 
patients enter the risk group for exposure to the virus, 
limiting the monitoring of the disease, impairing 
treatment. New health technologies and telemedicine 
have been on the rise in recent years, changing the 
course of medicine, research and health care. Its 
implementation and validation have been widely 
discussed in recent years, and it was greatly encouraged 
by the COVID-19 pandemic. To report the development, 
adaptations and the six-month longitudinal follow-up of 
20 individuals who underwent thyroidectomy at a 
university hospital. The research flowchart initially 
persisted in evaluating symptoms and vocal fatigue in 
individuals undergoing thyroidectomy due to thyroid 
cancer at three times: pre-surgical (M1), immediate 
post-surgical (M2) and late post-surgical (M3) in three 
to six months. The individuals were submitted to 
videolaryngoscopy, voice recording, voice acoustic 
analysis and completion of self-assessment protocols 
along with the medical consultation. All assessments 
were performed on an outpatient basis at the three 
times described.  The research began in October 2019, 
and was interrupted at the beginning of the pandemic. 
In February 2020 we obtained eight cases with the two 
initial assessments, and only two cases with M3. Due to 
the pandemic, the surgeries were suspended and the 
continuity of the study was impaired, requiring 
modifications. The initial goal was to last nine months 
with 30 individuals in the sample. New cases were 
followed up from October 2020 until May 2021 when 
there was a reduction in cases. At the end, all data from 
20 individuals in this period of the research were 
collected. The completion time increased from nine 
months to 20 months. None of the patients were 
infected by COVID-19 during the research period. 
Therefore, the treatment of cancer patients 
encompasses several aspects that have been hampered 
by its continuity, delaying deadlines and making access 
difficult by COVID-19. As well as, scientific research in 
this population has undergone several adaptations to 
preserve the health of individuals, not unnecessarily 
exposing them to contamination with the virus. 
Monitoring by telemedicine proved to be effective for the 
initial objectives of this study, but it may limit it 
depending on the type of proposed intervention. Despite 
the existing pandemic, scientific production should not 
be stopped because it brings discoveries that aim to 
improve the health of the population. 
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Introduction 
Scientific research brings resolutions to several 
problems in society, supporting clinical performance in 
health [1]. Development of various therapies, 
medications and surgeries, especially in oncology, is due 
to scientific research [2]. This always seeks scientific 
evolution and the best performance, minimizing risks 
and damages to individuals.  
As it is a more fragile population and with more 
risks, work with cancer patients needs to be even more 
careful [2,3]. Cancer itself brings several weaknesses to 
an individual's health. When exposed to surgery, 
systemic or radiotherapy treatment increases the 
damage and changes resulting from the disease and 
treatment [4,5]. 
Individuals who undergo cancer treatment suffer 
from a series of changes, especially those of head and 
neck cancer. Direct impacts on feeding, breathing and 
swallowing are easily identified in this population. 
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When undergoing surgery, the sequelae tend to be even 
greater in these functions, requiring continuous 
multiprofessional follow-up [6,7].  
During the COVID-19 pandemic, cancer patients 
enter the risk group for exposure to the virus, limiting 
the monitoring of the disease, impairing treatment [8,9]. 
There are signs of reduction in the diagnosis of cancer 
cases due to the difficulty in accessing health care. A 
reflection of this will possibly appear in the next few 
years with more aggressive cancers without curative 
treatment [8,9].  
New health technologies and telemedicine have 
been on the rise in recent years, changing the course of 
medicine, research and health care [10]. Its 
implementation and validation have been widely 
discussed in recent years, and it was greatly encouraged 
by the COVID-19 pandemic. To report the development, 
adaptations and the six-month longitudinal follow-up of 
20 individuals who underwent thyroidectomy at a 
university hospital. 
 
Experience report  
The research flowchart initially persisted in 
evaluating symptoms and vocal fatigue in individuals 
undergoing thyroidectomy due to thyroid cancer at 
three times: pre-surgical (M1), immediate post-surgical 
(M2) and late post-surgical (M3) in three to six months.  
The individuals were submitted to 
videolaryngoscopy, voice recording, voice acoustic 
analysis and completion of self-assessment protocols 
along with the medical consultation. All assessments 
were performed on an outpatient basis at the three 
times described.  
The self-assessment of symptoms and vocal 
fatigue was performed by three self-assessment 
protocols: Vocal Symptom Index (VSI), Thyroidectomy-
Related Voice and Symptom Questionnaire (TVSQ) – 
Brazilian Portuguese version and Vocal Fatigue Index 
(VFI). Sociodemographic data, clinical and surgical 
treatment were collected from medical records.  
The research began in October 2019, and was 
interrupted at the beginning of the pandemic. In 
February 2020 we obtained eight cases with the two 
initial assessments, and only two cases with M3. Due to 
the pandemic, the surgeries were suspended and the 
continuity of the study was impaired, requiring 
modifications. The initial goal was to last nine months 
with 30 individuals in the sample. 
Because it is public health, many patients had 
financial difficulties in going to the hospital at other 
times exclusively for the evaluation and refused to go 
due to the risk of COVID-19 infection. In non-urgent 
cases were suspense the videolaryngoscopy because of 
the high risk of infection as indicate the Otolaryngology 
Foundation. Reassessment cases were performed using 
online forms and voice recording from each individual's 
mobile device. Teleconsultations were also carried out 
to follow up the cases.  
New cases were followed up from October 2020 
until May 2021 when there was a reduction in cases. The 
researcher used the personal protective equipment 
indicated for COVID-19, following the guidelines of the 
World Health Organization, as well as easy-to-clean 
electronic materials, such as a computer, cell phone and 
tablet. The M2 and M3 assessments were defined as 
online by teleconsultation to avoid exposure and risks to 
individuals. 
At the end, all data from 20 individuals in this 
period of the research were collected. The completion 
time increased from nine months to 20 months. As the 
M2 and M3 assessments were online, there was no 
withdrawal of individuals in the period due to schedule 
adjustments and the lack of transportation. None of the 
patients were infected by COVID-19 during the research 
period. 
 
Reflection on experience  
Telemedicine proved to be a great tool for scientific 
research, helping to monitor the patient and continue 
the assessment. Being limited depending on the 
proposed procedures. The COVID-19 pandemic has 
limited access to health care for cancer patients, in 
addition to putting this population at greater risk of life. 
The use of technology was necessary to improve 
communication and keep scientific research viable, but 
some procedures are lost.  
The first care with the health of the researcher and 
the individual became the main objective of the 
research, as well as the performance of surgeries as 
soon as possible. Since the ICU beds, if necessary, were 
occupied by patients with COVID-19.  
The continuity of treatment with iodine therapy, as 
well as multidisciplinary follow-up with physiotherapy 
and speech therapy were hampered due to the difficulty 
in accessing these treatments due to the pandemic. 
Limited public resources, great burden on health 
professionals and the fear of infection by COVID-19 
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this population has undergone several adaptations to 
preserve the health of individuals, not unnecessarily 
exposing them to contamination with the virus. 
Monitoring by telemedicine proved to be effective for the 
initial objectives of this study, but it may limit it 
depending on the type of proposed intervention. Despite 
the existing pandemic, scientific production should not 
be stopped because it brings discoveries that aim to 
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